Works matching IS 1699048X AND DT 2016 AND VI 18 AND IP 10

Results: 12

Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 988, doi. 10.1007/s12094-015-1471-z
By:
- Orlandi, A.;
- Calegari, M.;
- Martini, M.;
- Cocomazzi, A.;
- Bagalà, C.;
- Indellicati, G.;
- Zurlo, V.;
- Basso, M.;
- Cassano, A.;
- Larocca, L.;
- Barone, C.
Publication type:
Article
Ki-67 is a prognostic marker for hormone receptor positive tumors.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 996, doi. 10.1007/s12094-015-1472-y
By:
- Pérez-López, M.;
- García-Gómez, J.;
- Alves, M.;
- Paradela, A.;
- García-Mata, J.;
- García-Caballero, T.
Publication type:
Article
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1003, doi. 10.1007/s12094-015-1473-x
By:
- Trovo, M.;
- Giaj-Levra, N.;
- Furlan, C.;
- Bortolin, M.;
- Muraro, E.;
- Polesel, J.;
- Minatel, E.;
- Tedeschi, R.;
- Filippi, A.;
- Alongi, F.;
- Ricardi, U.
Publication type:
Article
Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1011, doi. 10.1007/s12094-015-1475-8
By:
- Rico, M.;
- Martínez, E.;
- Pellejero, S.;
- Bermejo, B.;
- Navarrete, P.;
- Barrado, M.;
- Campo, M.;
- Mañeru, F.;
- Villafranca, E.;
- Aristu, J.
Publication type:
Article
Signaling and molecular basis of bone marrow niche angiogenesis in leukemia.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 957, doi. 10.1007/s12094-015-1477-6
By:
- Shirzad, R.;
- Shahrabi, S.;
- Ahmadzadeh, A.;
- Kampen, K.;
- Shahjahani, M.;
- Saki, N.
Publication type:
Article
Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1019, doi. 10.1007/s12094-015-1479-4
By:
- Huang, Z.;
- Xu, D.;
- Zhang, F.;
- Ying, Y.;
- Song, L.
Publication type:
Article
Role of taxanes in advanced prostate cancer.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 972, doi. 10.1007/s12094-015-1480-y
By:
- Cassinello, J.;
- Carballido Rodríguez, J.;
- Antón Aparicio, L.
Publication type:
Article
The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1026, doi. 10.1007/s12094-016-1481-5
By:
- Gomez-Iturriaga, A.;
- Cabeza, Á.;
- Pastor, J.;
- Jove, J.;
- Casaña, M.;
- Caamaño, A.;
- Mengual, J.;
- Henríquez, I.;
- Muñoz, J.;
- Hervás, A.;
- Segundo, C.
Publication type:
Article
Long-term visual outcomes in intraocular retinoblastoma with eye preservation.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1034, doi. 10.1007/s12094-016-1482-4
By:
- Batra, A.;
- Pushker, N.;
- Venkatesh, P.;
- Arora, T.;
- Tewari, R.;
- Bakhshi, S.
Publication type:
Article
Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1039, doi. 10.1007/s12094-016-1483-3
By:
- Nicoś, M.;
- Krawczyk, P.;
- Jarosz, B.;
- Sawicki, M.;
- Michnar, M.;
- Trojanowski, T.;
- Milanowski, J.
Publication type:
Article
Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 1044, doi. 10.1007/s12094-016-1484-2
By:
- Martín-Algarra, S.;
- Cruz-Merino, L.;
- Soriano, V.;
- Manzano, J.;
- Espinosa, E.
Publication type:
Article
Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
Published in:
Clinical & Translational Oncology, 2016, v. 18, n. 10, p. 981, doi. 10.1007/s12094-015-1470-0
By:
- Moreno, L.;
- Linossi, C.;
- Esteban, I.;
- Gadea, N.;
- Carrasco, E.;
- Bonache, S.;
- Gutiérrez-Enríquez, S.;
- Cruz, C.;
- Díez, O.;
- Balmaña, J.
Publication type:
Article